First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33812267/
Our real-world data demonstrated that ET-CDKi represents the best option for 1 st L luminal-MBC compared to ET and CT. Also, the present study pointed out that 2 nd L...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • In the current study published in Breast, Italian researchers compared endocrine therapy (ET) plus cyclin-dependent-kinases 4/6 inhibitors (CDK4/6i) for the treatment of 717 patients with luminal-metastatic breast cancer Show More
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33996251/
doi: 10.1016/j.omtn.2021.04.001. 1 Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. 2 Urology Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD,...
ESMO 2020: highlights in breast cancer
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090520/
Despite the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, results of several pertinent studies in the field of breast cancer (BC) were presented in a virtual format at...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • This article sums up the findings from several key trials presented at ESMO 2020. Here’s a look at two similar trials with contradicting results: MonarchE and the PALLAS Show More
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • This article sums up the findings from several key trials presented at ESMO 2020. Here’s a look at two similar trials with contradicting results: MonarchE and the PALLAS trial. • In Show More
44-Year-Old Female with Locally Advanced Breast Cancer
Nancy, a 44-year-old woman of five, was referred for treatment of locally advanced breast cancer. She had a massive tumor with skin thickening in her right breast. Ultrasound was used instead of mammography due to the hardness of her right breast — revealing pronounced skin thickening, an...
-
Breast Cancer Connect5yrThanks for your input, [~DONALD--FLEMING--dfleming1@ ] and [[email protected]] ! In their responses, both active cancer treatment and palliative care were mentioned. What are your thoughts? Please share.
-
Naveed Saleh, MD, MS – Skipta Team5yrThanks for your input [~DONALD--FLEMING--dfleming1@ ] and [[email protected]] ! In their responses, both active treatment and palliative care were mentioned. What are your thoughts? Please share.
Show More Comments
UChicago study finds lasofoxifene a promising treatment for resistant breast cancer
Source : https://www.eurekalert.org/pub_releases/2021-05/uocm-usf051321.php
In a study carried out in mice at the University of Chicago, researchers found that lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary tumor growth. It...